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 The review article by Vally and Misso (1) 
published in the current edition of this journal 
outlines the broad range of signs and symptoms 
associated with sulphite sensitivity. These include 
bronchoconstriction, wheezing, dyspnea, nausea, 
stomach cramps, diarrhoea, urticaria/angiodema, 
diaphoresis, hives, laryngeal oedema, generalised 
itching and swelling, tingling sensations, flushing, 
hypotension, cyanosis, shock and loss of 
consciousness (2). Many of the symptoms mirror 
those of anaphylaxis.  Indeed reactions to sulphites 
can be life threatening, as a number of fatal cases 
have been reported (3, 4). In many areas of the 
world, sulphites are now one of the potential 
allergens (along with the likes of peanuts, fish, 
crustaceans, gluten and milk) that have to be labelled 
on food and drink products. In the European Union 
(EU), levels in foods and drinks above 10 mg/kg or 
10 mg per litre have to be labelled. Warning labels 
are now commonplace, yet in practice there is still a 
huge amount of ignorance and misinformation about 
the use of sulphites in food, drinks and 
pharmaceutical products. Hence, Clinicians need to 
be aware of sulphite sensitivity in order to enable 
appropriate diagnosis and provide recommendations 
for treatment.  
Precautions are recommended in a hospital 
setting where common pharmaceutical drugs, 
foods and beverages may cause reactions in 
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sulphite sensitive individuals, particularly as 
sulphites are used in many commonly used drugs 
including some formulations of paracetamol, 
zithromax, epinephrine (5). It would also be 
important to consider the combined potential 
exposure a sensitive individual may encounter 
within a hospital or surgical environment from 
food, drink and pharmaceutical sources.  
A low sulphite diet would be recommended if a 
sulphite sensitive patient is hospitalised in addition 
to avoidance of pharmaceutical products 
containing sulphites wherever possible. 
Management of a sulphite sensitive individual 
undergoing anaesthesia also presents particular 
challenges given sulphites may be in both local 
anaesthetic agents and epinephrine. It is important 
to remember risks may also be present for 
individuals that do not know they have a sulphite 
sensitivity, for example as in the case report of 
anaphylactic shock during epidural anaesthesia for 
caesarean section as a result of exposure to 
metabisulphite (6). 
A report from the World Health Organisation 
International Programme on Chemical Safety states 
the ADI is 0 - 0.07 mg/kg body weight (7). In a low 
sulphite diet levels would need to be minimised as 
much as possible. This probably represents a major 
challenge for both clinicians and hospital catering 
staff given the many widespread and varied uses of 
sulphites. For example, sulphites can be used to 
modify the texture of dough, as the breaking of 
disulphide bonds weakens dough making it suitable 
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for crackers and pizza bases (8). Sulphites can also 
occur naturally in foods and drinks e.g. 
saccharomyces cerevisiae generates between 1-30 
parts per million (ppm) SO2 in fermentation and some 
strains produce in excess of 100 ppm (9). Levels of 
sulphites in foods can be as high as over 4,000 ppm, 
some examples are detailed in the tables 1-5.   
 
Table 1.  Examples of high sulphite level foods 
(>100 ppm SO2) (10) 
Wine 
Molasses 
Sauerkraut 
Lemon juice (non-frozen) 
Dried fruit (excluding dark raisins and prunes) 
 
Lester (10) classifies a food with a level of 100 
ppm SO2 or more as a high sulphite food, foods 
with a sulphite level of 50 – 99.9 ppm as moderate 
sulphite level foods and foods with 10 - 49.9 ppm 
as low sulphite foods (Tables 1-3). These should 
be avoided as much as possible by a sulphite 
sensitive individual, who should be counselled on 
suitable food choices by an appropriate health 
professional. Nutritional strategies for the 
management of sulphite sensitive individual 
would probably need to include the avoidance of 
many pre-prepared, packaged foods and drinks 
containing sulphites at levels above 10 mg/kg or 
10 mg per litre with specific avoidance of food 
containing the sulphite additives. 
 
Table 2.  Examples of moderate sulphite level foods 
(50-99.9 ppm SO2) (10) 
Dried potatoes 
Grape juice 
Wine vinegar 
Gravies, sauces 
Fruit topping  
Maraschino cherries 
 
There are eleven different ways of measuring 
sulphite levels in foods (8). The Optimized 
Monier-Williams method measure total SO2 (11). 
The FDA in the U.S.A. uses the Optimized 
Monier-Williams method for official samples. As 
sulphites exist in many different forms and as 
sulphite salts release SO2, sulphite levels are 
usually expressed as SO2 equivalents (SDE). 
However, the Optimized Monier-Williams method 
can give false positives as naturally occurring 
sulphur chemicals e.g. in brassicas and garlic will 
yield SO2 readings (8).  It is also important to 
remember that the storage and preparation of 
foods can also affect the levels of sulphite (11). 
Sulphites may be lost as a result of autoxidation, 
for example when a packet or jar is opened and 
exposed to air (2). Packaging may also affect 
sulphite levels, as there may be a complete loss of 
sulphites from plastic bottles, whereas glass 
bottles seem to prevent the loss of sulphites (2). 
 
Table 3.  Examples of low sulphite level foods (10-
49.9 ppm SO2) (10) 
Pectin 
Shrimp (fresh) 
Corn starch 
Corn syrup 
Pickles/relishes 
Frozen potatoes 
Imported jams and jellies 
Maple syrup 
 
Table 4. Sulphite levels in imported foods (8) 
Food Sulphite Levels (ppm SO2) 
Dried bamboo shoots 2100 
Dried apple 750 
Ginger 1900 
Sweet coconut 375 
Dried abalone 11000 
Sun-dried tomatoes 800 
Shrimp 600 
 
Normally ingested sulphite is oxidised to 
sulphate by the enzyme sulphite oxidase (SO) and 
then excreted in the urine. Approximately 16-24 
mmol of inorganic sulphate is excreted daily (2).  
SO is normally widely distributed in the human 
body, with the highest amounts found in the liver 
and kidneys. Hence, it may be likely that pathologies 
of these organs may increase the likelihood of 
sensitivity to sulphites. There are several 
documented cases of sulphite oxidase (SO) 
Bold J  5 
Gastroenterol Hepatol Bed Bench 2012;5(1):3-6 
deficiency (12). This was associated with severe 
neurological abnormalities and retardation.  Animal 
studies of induced SO deficiency, have shown that it 
increases sensitivity to dietary sulphites (13). Hence, 
low levels of this enzyme may play a role in sulphite 
sensitivity in humans. Molybdenum deficiency may 
be a cause of an apparent case of induced sulphite 
oxidase deficiency (14). Hence, lack of enzymatic 
co-factors may also be a contributory factor.  
 
Table 5. Food additives containing sulphites 
E Number  Name 
E220 Sulphur dioxide 
E221 Sodium sulphite 
E222 Sodium hydrogen sulphite 
E223 Sodium metabisulphite 
E224 Potassium metabisulphite 
E226 Calcium sulphite 
E227 Calcium hydrogen sulphite 
E228 Potassium hydrogen sulphite 
E150  Sulphited colour caramels (E150 b/d) 
 
A SO2 metabolite (glutathione S-sulfonate) has 
been demonstrated in studies on rat liver, lung and 
human lung cells to be a competitive inhibitor of 
the liver enzyme glutathione S-transferase (GST) 
(15). Researchers suggested that SO2 may have a 
detrimental effect on the general detoxification of 
xenobiotic compounds generally detoxified in the 
glutathione conjugation pathway, involving GST 
(15).  They suggest it may deplete glutathione 
supply and it could be a contributory factor in 
sulphite sensitivity.  Obviously, further studies 
would be required to validate this. 
In terms of diagnosis, the literature shows that 
oral challenge tests and measurements of FEV and 
FEV at intervals after challenge have been widely 
used to diagnose sulphite sensitivity. Obviously, it 
is vital that a clinician takes a full medical history, 
establishes if the patient is asthmatic/atopic and 
analyses symptoms associated with a reaction and 
rules out other factors (e.g. other allergic reaction, 
histamine contamination or food poisoning). 
Consideration of appropriate laboratory tests to 
rule of infection would also be important (16). The 
clinician may also need to eliminate other factors 
such as coeliac disease, where diagnosis can also 
be challenging especially where presentation is 
atypical (17). 
Oral challenges have been undertaken to a 
variety of sulphites (e.g. sodium MBS and SO2) in 
both capsule form and in solution. Oral challenge 
can result in severe reactions; hence they are 
usually undertaken in a hospital environment. 
Many studies have reported that IgE tests have 
been inconclusive, however a specific IgE 
antibody to sulphites has been reported (18).  
Intradermal patch testing and prick testing has 
also been used to diagnose sensitivity (19, 9). A 
study was undertaken to determine validity of 
patch testing for sulphite sensitivity (20). Sulphite 
sensitivity was confirmed in 12 cases out of the 13 
cases (92%). Whilst the sample size is limited, it 
would seem that patch testing might have potential 
as a way of diagnosing sulphite sensitivity. Further 
research would be required in this area.  
In terms of clinical management of signs and 
symptoms, sodium cromoglycate has been shown to 
block sulphite induced asthma (21).  Corticosteroids 
may also be prescribed in the case of a severe 
reaction and bronchoconstriction may be treated with 
nebulisation or bronchodilators.  It is important to 
ensure that any prescribed medication is free from 
sulphites, as some corticosteroids contain sulphites 
(e.g. dexametahsone) and many asthma medications 
(e.g. isoetharine) contain sodium bisulphite (5). The 
author notes a sulphite free epinephrine inhaler, is 
available for the management of bronchial asthma is 
some areas of the world. This may be of use in the 
management of a sulphite sensitive individual. If IgE 
mediated reactions are suspected then anti-
histamines may be useful.  
Oral administration (prior to ingestion of sulphite) 
of 1-5mg of vitamin B12 (cyanocobalamin) 
completely or partially blocked bronchoconstriction 
from sulphite sensitivity in a study of six patients (22). 
It was proposed that might be due to the role of B12 
as a co-factor in sulphite oxidation, where sulphites 
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are converted to sulphates by the enzyme Sulphite 
oxidase (SO).  A limitation of this study is the small 
number of subjects however B12 is readily available, 
economical and administration has few risks hence 
may be worthy of consideration by the Physician.  It is 
reported that the drug Doxepin also blocked 
bronchoconstriction caused by sulphites (22). 
Sulphite sensitivity whilst rare is serious and 
consequently clinicians need to be aware of the 
challenges in diagnosis and treatment. There is 
undoubtedly a need for interprofessional collaboration 
to ensure effective diagnosis and management. Best 
practice in the management of a sulphite sensitive 
individual is also an important area for future 
consideration. 
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